ORIC is a privately held venture-backed company dedicated to understanding mechanisms of resistance to cancer treatment, and to discovering and developing therapies to overcome resistance in cancer. The company was founded by doctors Charles Sawyers and Scott Lowe of Memorial Sloan Kettering Cancer Center, who have strong records of discovering innovative cancer targets and treatments.
